Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- PVLA
- Price
- 80.09
- Stock movement down
- -1.45 (-1.78%)
- Company name
- Palvella Therapeutics, Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 947.98M
- Ent value
- 912.67M
- Price/Sales
- -
- Price/Book
- 24.51
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -27.92%
- 1 year return (CAGR)
- 300.45%
- 3 year return (CAGR)
- -16.02%
- 5 year return (CAGR)
- -19.27%
- 10 year return (CAGR)
- -4.40%
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
PVLA does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 24.51 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 11.84M |
| EPS (TTM) | -2.98 |
| FCF per share (TTM) | -2.30 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -31.66M |
| Net income (TTM) | -32.95M |
| EPS (TTM) | -2.98 |
| EPS (1y forward) | -4.04 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 63.57M |
| Net receivables | 2.22M |
| Total current assets | 66.94M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 66.94M |
| Accounts payable | 3.48M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 10.31M |
| Total liabilities | 28.25M |
| Shareholder's equity | 38.68M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -25.47M |
| Capital expenditures (TTM) | 13.00K |
| Free cash flow (TTM) | -25.49M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -85.19% |
| Return on Assets | -49.23% |
| Return on Invested Capital | -85.19% |
| Cash Return on Invested Capital | -65.89% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 79.00 |
| Daily high | 80.87 |
| Daily low | 78.00 |
| Daily Volume | 224K |
| All-time high | 756.00 |
| 1y analyst estimate | 187.87 |
| Beta | - |
| EPS (TTM) | -2.98 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PVLA | S&P500 | |
| Current price drop from All-time high | -89.41% | -1.82% |
| Highest price drop | -99.14% | -56.47% |
| Date of highest drop | 11 Jul 2024 | 9 Mar 2009 |
| Avg drop from high | -63.93% | -10.84% |
| Avg time to new high | 38 days | 12 days |
| Max time to new high | 2013 days | 1805 days |
COMPANY DETAILS
Marketcap
947.98M
Marketcap category
Small-cap
Description
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania
Employees
14
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner